✦ LIBER ✦

Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: Results of a randomized phase 3 trial

✍ Scribed by Coen R. N. Rasch; Michael Hauptmann; Jan Schornagel; Oda Wijers; Jan Buter; Theo Gregor; Ruud Wiggenraad; Jan Paul de Boer; Annemiek H. Ackerstaff; Robert Kroger; Frank J. P. Hoebers; Alfons J. M. Balm

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 208 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24916

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum: Intra-arterial versus intraveno

Erratum: Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: Results of a randomized phase 3 trial

✍ CRN Rasch; M Hauptmann; J Schornagel; O Wijers; J Buter; T Gregor; R Wiggenraad; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Alternating chemoradiotherapy versus par

Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck : Results from a phase III randomized trial

✍ Renzo Corvò; Marco Benasso; Giuseppe Sanguineti; Rita Lionetto; Almalina Bacigal 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

## BACKGROUND. The authors previously have found that in patients with locally advanced squamous cell carcinoma of the head and neck (SCC-HN), alternating chemoradiotherapy (ALT) was superior to low-total-dose conventional radiotherapy alone. The purpose of this randomized trial was to compare the

Taxane-based chemoirradiation for organ

Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: Results of a phase II multi-institutional trial

✍ Anthony J. Cmelak; Barbara A. Murphy; Brian Burkey; Stacy Douglas; Yu Shyr; Jame 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 1 views

## Abstract ## Background. The optimal drug schedule and sequencing of chemotherapy and radiation for organ preservation in head and neck cancer has yet to be determined. We undertook a phase II trial of a taxane‐based induction chemotherapy (ICT) followed by a taxane‐based concurrent chemoradiati

Chemotherapy of advanced head and neck c

Chemotherapy of advanced head and neck cancer: Updated results of a randomized trial of the order of administration of sequential methotrexate and 5-fluorouracil

✍ MacKintosh, John F. ;Coates, Alan S. ;Tattersall, M. H. N. ;Swanson, Cheryl 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB

One hundred and twenty-seven patients with advanced or recurrent squamous cell carcinoma of the head and neck (HNC) were randomized to treatment with methotrexate (MTX) followed 1 hour later by 5-fluorouracil (5-FU) (sequence MF), or 5-fluorouracil followed after 1 hour by methotrexate (sequence FM)

Neurotoxicity in a phase I trial of cont

Neurotoxicity in a phase I trial of continuous-infusion cisplatin with hyperfractionated radiotherapy for locally advanced head and neck cancer

✍ Gerald H. Clamon; Lynn Baatz; Henry T. Hoffman; David H. Hussey; Matthew Glascoc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

## Background: Both twice daily fractionated radiotherapy and concurrent cisplatin with once-daily radiotherapy have been shown to improve local disease control in patients with head and neck cancer. the objective of this phase i trial was to determine the maximum tolerated dose of cisplatin which

A randomized phase 2 trial comparing 3-h

A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer

✍ Stacy L. Moulder; Frankie A. Holmes; Anthony W. Tolcher; Peter Thall; Kristine B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

## Abstract ## BACKGROUND: This study was performed to compare efficacy and toxicity profiles of paclitaxel using 3‐hour versus 96‐hour infusion schedules. ## METHODS: Patients with metastatic breast cancer (MBC) were randomly assigned to receive paclitaxel starting at a dose of 250 mg/m^2^ intr